health pharma news today obesity drugs glp-1 today What is the pipeline for future medications for obesity? GLP‑1 real‑world data for obesity:
Description
M., Martinou, E
Vaduganathan M, Docherty KF, Claggett BL, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, et al
J.PatelM
24 Medications often used in IIH have been shown to exacerbate cognitive deficits in patients, with acetazolamide and topiramate impairing fluid intelligence
